EMA
guidance
· 2022-11-11
New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome
Summary
EMA has issued new recommendations for terlipressin-containing medicines used to treat hepatorenal syndrome, outlining updated safety and usage guidance.
Upgrade for the full analysis, importance score, and drug timeline.